Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metronidazole

S M Finegold

    Annals of Internal Medicine
    |October 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Metronidazole is effective against various infections, including Trichomonas and amebiasis, and penetrates tissues well. While generally well-tolerated, potential risks like mutagenicity and carcinogenicity require careful benefit-risk assessment by physicians and patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Corynebacterium pyruviciproducens promotes the production of ovalbumin specific antibody via stimulating dendritic cell differentiation and up-regulating Th2 biased immune response.

    Vaccine·2011
    Same author

    Quantitative detection of enterotoxigenic Bacteroides fragilis subtypes isolated from children with and without diarrhea.

    Journal of clinical microbiology·2010
    Same author

    Innate immune recognition of, and response to, Clostridium sordellii.

    Anaerobe·2009
    Same author

    Evaluation of genotypic and phenotypic methods for differentiation of the members of the Anginosus group streptococci.

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2009
    Same author

    Study of the in vitro activities of rifaximin and comparator agents against 536 anaerobic intestinal bacteria from the perspective of potential utility in pathology involving bowel flora.

    Antimicrobial agents and chemotherapy·2008
    Same author

    National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004.

    Antimicrobial agents and chemotherapy·2007
    Same journal

    Correction to I.M. Matters News: Sleep medicine for seniors.

    Annals of internal medicine·2026
    Same journal

    Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone : A Target Trial Emulation.

    Annals of internal medicine·2026
    Same journal

    Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

    Annals of internal medicine·2026
    Same journal

    Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

    Annals of internal medicine·2026
    Same journal

    Weekly and Biweekly Treatment With Bofanglutide Versus Semaglutide in Chinese Patients With Type 2 Diabetes : A Phase 2b Randomized Clinical Trial.

    Annals of internal medicine·2026
    Same journal

    Grappling with GLP-1 prescribing.

    Annals of internal medicine·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Microbiology
    • Infectious Diseases

    Background:

    • Metronidazole is an approved antimicrobial agent.
    • It exhibits broad-spectrum activity against anaerobic bacteria and protozoa.
    • Its pharmacokinetic properties allow for good tissue penetration, including the central nervous system.

    Purpose of the Study:

    • To review the approved indications and emerging uses of metronidazole.
    • To evaluate the efficacy and safety profile of metronidazole.
    • To discuss the risks and benefits associated with metronidazole therapy.

    Main Methods:

    • Literature review of clinical studies and pharmacological data.
    • Analysis of adverse reaction reports and long-term patient follow-up data.

    Related Experiment Videos

  • Assessment of mutagenicity and carcinogenicity studies in animal models.

    • Main Results:

    • Metronidazole is effective against Trichomonas infection, amebiasis, giardiasis, and anaerobic infections.
    • The drug is well-tolerated with minor impact on colonic flora.
    • Adverse effects include neutropenia, neuropathy, and disulfiram-like reactions; mutagenicity/carcinogenicity are low risks in humans.

    Conclusions:

    • Metronidazole is a valuable therapeutic option for specific infections.
    • Physicians and patients must weigh the benefits against potential risks, especially mutagenicity and carcinogenicity.
    • Use should be limited to approved indications and not for prophylaxis, despite its efficacy.